Assessing the therapeutic and toxicological profile of novel GLP-1 receptor agonists for type 2 diabetes.
評估新型 GLP-1 受體激動劑在 2 型糖尿病中的治療和毒理特徵。
Expert Opin Drug Metab Toxicol 2024-09-13
Role of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiovascular Risk Management in Patients With Type 2 Diabetes Mellitus: A Systematic Review.
GLP-1受體激動劑在第2型糖尿病患者心血管風險管理中的作用:系統性回顧。
Cureus 2023-10-21
A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists.
使用胰高血糖素樣肽-1受體激動劑的安全性和有效性評論與荟萃分析。
Medicina (Kaunas) 2024-03-30
A review of serious adverse events linked with GLP-1 agonists in type 2 diabetes mellitus and obesity treatment.
與 GLP-1 受體激動劑在 2 型糖尿病及肥胖治療中相關的嚴重不良事件回顧。
Pharmacol Rep 2024-08-02